Semaglutide (Ozempic/Wegovy/Rybelsus) is a drug for the treatment of type 2 diabetes, which belongs to the group of analogues of glucagon–like peptide-1 (GLP-1). It is used to improve blood sugar control in patients with type 2 diabetes.
Semaglutide acts by stimulating insulin secretion and increasing the sensitivity of cells to insulin. This helps to lower blood sugar levels and prevent the development of diabetes complications.
The drug is recommended for use in patients with type 2 diabetes mellitus who cannot control their sugar levels through diet, physical activity and drugs that reduce sugar levels.
The drug is taken once a day, preferably in the morning, 30 minutes before meals or 2 hours after meals. The dose of the drug is selected individually depending on the sugar level and other factors.
Before starting the use of Semaglutide, it is necessary to consult a doctor and undergo the necessary examinations.
Side effects may include hypoglycemia (decreased blood sugar), nausea, vomiting, diarrhea, constipation, abdominal pain, headache, dizziness, and allergic reactions. If you notice any of these symptoms, contact your doctor.
In case of overdose, it is necessary to consult a doctor immediately. Overdose can cause hypoglycemia.
If you missed a dose of Semaglutide, take it as soon as possible, but no later than the time specified in the instructions. Do not take a double dose to compensate for the missed one.